REQUEST A DEMO
Total
USD $0.00
Search more companies

Smp Clinical Development SRL (Romania)

Main Activities: Data Processing, Hosting, and Related Services
Full name: Smp Clinical Development SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Smp Clinical Development SRL is a company in Romania, with a head office in BRASOV. The company operates in the Data Processing, Hosting, and Related Services sector. It was incorporated on February 19, 2003. 3 (2022) employees currently work for Smp Clinical Development SRL. From the latest financial highlights, Smp Clinical Development SRL reported a net sales revenue increase of 53.2% in 2023. There was a total negative growth of 43.34% in Smp Clinical Development SRL’s total assets over the same period. The enterprise’s net profit margin increased by 19.83% in 2023.

Headquarters
Strada Calugareni Nr. 17
BRASOV; Brasov; Postal Code: 500182

Contact Details: Purchase the Smp Clinical Development SRL report to view the information.

Basic Information
Total Employees:
Purchase the Smp Clinical Development SRL report to view the information.
Outstanding Shares:
Purchase the Smp Clinical Development SRL report to view the information.
Registered Capital:
Purchase the Smp Clinical Development SRL report to view the information.
Incorporation Date:
February 19, 2003
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Smp Clinical Development SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
53.2%
Total operating revenue
53.15%
Operating profit (EBIT)
140.4%
EBITDA
136.64%
Net Profit (Loss) for the Period
147.51%
Total assets
-43.34%
Total equity
-43.91%
Operating Profit Margin (ROS)
19.21%
Net Profit Margin
19.83%
Return on Equity (ROE)
74.62%
Quick Ratio
-8.3%
Cash Ratio
-10.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?